|
[1]LINDKVIST B,BENITO de VALLE M,GULLBERG B,et al.Incidence and prevalence of primary sclerosing cholangitis in a defined adult population in Sweden[J].Hepatology,2010,52(2):571-577.
|
|
[2]BOONSTRA K,BEUERS U,PONSIOEN CY.Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis:a systematic review[J].J Hepatol,2012,56(5):1181-1188.
|
|
[3]MOLODECKY NA,KAREEMI H,PARAB R,et al.Incidence of primary sclerosing cholangitis:a systematic review and meta-analysis[J].Hepatology,2011,53(5):1590-1599.
|
|
[4]STANICH PP,BJORNSSON E,GOSSARD AA,et al.Alkaline phosphatase normalization is associated with better prognosis in primary sclerosing cholangitis[J].Dig Liver Dis,2011,43(4):309-313.
|
|
[5]FREEMAN ML,NELSON DB,SHERMAN S,et al.Complications of endoscopic biliary sphincterotomy[J].N Engl J Med,1996,335(13):909-918.
|
|
[6]BANGARULINGAM SY,GOSSARD AA,PETERSEN BT,et al.Complications of endoscopic retrograde cholangiopancreatography inprimary sclerosing cholangitis[J].Am J Gastroenterol,2009,104(4):855-860.
|
|
[7]DAVE M,ELMUNZER BJ,DWAMENA BA,et al.Primary sclerosing cholangitis:meta-analysis of diagnostic performance of MR cholangiopancreatography[J].Radiology,2010,256(2):387-396.
|
|
[8]BERSTAD AE,AABAKKEN L,SMITH HJ,et al.Diagnostic accuracy of magnetic resonance and endoscopic retrograde cholangiography in primary sclerosing cholangitis[J].Clin Gastroenterol Hepatol,2006,4(4):514-520.
|
|
[9]ANGULO P,MAOR-KENDLER Y,LINDOR KD.Small-duct primary sclerosing cholangitis:a long-term follow-up study[J].Hepatology,2002,35(6):1494-1500.
|
|
[10]BOONSTRA K,WEERSMA RK,van ERPECUM KJ,et al.Population-based epidemiology,malignancy risk,and outcome of primary sclerosing cholangitis[J].Hepatology,2013,58(6):2045-2055.
|
|
[11]MENDES FD,JORGENSEN R,KEACH J,et al.Elevated serum Ig G4 concentration in patients with primary sclerosing cholangitis[J].Am J Gastroenterol,2006,101(9):2070-2075.
|
|
[12]LINDOR KD.Ursodiol for primary sclerosing cholangitis.Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group[J].N Engl J Med,1997,336(10):691-695.
|
|
[13]TRIANTOS CK,KOUKIAS NM,NIKOLOPOULOU VN,et al.Meta-analysis:ursodeoxycholic acid for primary sclerosing cholangitis[J].Aliment Pharmacol Ther,2011,34(8):901-910.
|
|
[14]POROPAT G,GILJACA V,STIMAC D,et al.Bile acids for liver-transplanted patients[J].Cochrane Database Syst Rev,2010,(3):cd005442.
|
|
[15]OLSSON R,BOBERG KM,de MUCKADELL OS,et al.High-dose ursodeoxycholic acid in primary sclerosing cholangitis:a 5-year multicenter,randomized,controlled study[J].Gastroenterology,2005,129(5):1464-1472.
|
|
[16]WUNSCH E,TROTTIER J,MILKIEWICZ M,et al.Prospective evaluation of ursodeoxycholic acid withdrawal in patients with primary sclerosing cholangitis[J].Hepatology,2014,60(3):931-940.
|
|
[17]BALUYUT AR,SHERMAN S,LEHMAN GA,et al.Impact of endoscopic therapy on the survival of patients with primary sclerosing cholangitis[J].Gastrointest Endosc,2001,53(2):308-312.
|
|
[18]van MILLIGEN de WIT AW,van BRACHT J,RAUWS EA,et al.Endoscopic stent therapy for dominant extrahepatic bile duct strictures in primary sclerosing cholangitis[J].Gastroin test Endosc,1996,44(2):293-299.
|
|
[19]HIRSCHFIELD GM,KARLSEN TH,LINDOR KD,et al.Primary sclerosing cholangitis[J].Lancet,2013,382(9904):1587-1599.
|
|
[20]NAKAZAWA T,NAITOH I,HAYASHI K,et al.Inflammatory bowel disease of primary sclerosing cholangitis:a distinct entity?[J].World J Gastroenterol,2014,20(12):3245-3254.
|
DownLoad: